196 related articles for article (PubMed ID: 2612231)
1. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function.
Conte JE
Antimicrob Agents Chemother; 1987 Oct; 31(10):1585-8. PubMed ID: 3435107
[TBL] [Abstract][Full Text] [Related]
3. Cefpiramide kinetics and plasma protein binding in cholestasis.
Demontes-Mainard F; Vinçon G; Labat L; Amouretti M; Necciari J; Kieffer G; Bannwarth B
Br J Clin Pharmacol; 1994 Mar; 37(3):295-7. PubMed ID: 8198940
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefepime in subjects with renal insufficiency.
Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.
Ohkawa M; Hirano S; Tokunaga S; Motoi I; Shoda R; Ikeda A; Sugata T; Sawaki M; Shimamura M; Okasho A; Kuroda K
Antimicrob Agents Chemother; 1983 Jan; 23(1):31-5. PubMed ID: 6572490
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K
Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
[TBL] [Abstract][Full Text] [Related]
8. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
[TBL] [Abstract][Full Text] [Related]
10. Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency.
van Dalen R; Vree TB; Hafkenscheid JC; Gimbrère JS
J Antimicrob Chemother; 1979 May; 5(3):281-92. PubMed ID: 479064
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal function.
Ohkawa M; Takamae K; Shimamura M; Kuroda K; Awazu S
Chemotherapy; 1981; 27(3):149-54. PubMed ID: 7226971
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefpiramide (SM-1652) in humans.
Nakagawa K; Koyama M; Matsui H; Ikeda C; Yano K; Nakatsuru N; Yoshinaga K; Noguchi T
Antimicrob Agents Chemother; 1984 Feb; 25(2):221-5. PubMed ID: 6712202
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function.
Kowalsky SF; Echols RM; Venezia AR; Andrews EA
Antimicrob Agents Chemother; 1983 Aug; 24(2):151-5. PubMed ID: 6314884
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cefamandole in patients with renal impairment.
Czerwinski AW; Pederson JA
Antimicrob Agents Chemother; 1979 Feb; 15(2):161-4. PubMed ID: 426510
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.
Bressolle F; Brès J; Mourad G
Clin Pharmacokinet; 1989 Nov; 17(5):367-73. PubMed ID: 2582694
[TBL] [Abstract][Full Text] [Related]
16. The effect of impairment of renal function and dialysis on the serum and urine levels of clindamycin.
Peddie BA; Dann E; Bailey RR
Aust N Z J Med; 1975 Jun; 5(3):198-202. PubMed ID: 1057932
[TBL] [Abstract][Full Text] [Related]
17. Experimental and clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new cephalosporin with high hepatic elimination.
Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
Drugs Exp Clin Res; 1988; 14(8):519-27. PubMed ID: 3248507
[TBL] [Abstract][Full Text] [Related]
18. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.
Nissenson AR; Levin NW; Parker RH
Clin Pharmacol Ther; 1972; 13(6):887-94. PubMed ID: 5081601
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
Loffreda A; Lampa E; Lucarelli C; Amorena M; Contaldi C; Calderaro V; Rossi F
Chemotherapy; 1999; 45(1):1-7. PubMed ID: 9876203
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
